Pregnancy-associated thrombotic thrombocytopenic purpura

Thrombosis and Haemostasis

Volumn 101, Issue 2, 2009, Pages 248-251

  Gerth, Jens ^a   Schleussner, Ekkehard ^a   Kentouche, Karim ^a   Busch, Martin ^a   Seifert, Mandy ^a   Wolf, Gunter ^a,b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

ADAMTS 13; Plasmapheresis; Pregnancy; Thrombocytopenia; Thrombotic thrombocytopenic purpura; Von willebrand factor

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; ENOXAPARIN; FRESH FROZEN PLASMA; GLUCOCORTICOID; HEMOGLOBIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLDOPA; PREDNISOLONE; PREDNISONE; RAMIPRIL; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; AUTOANTIBODY; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; CLINICAL EXAMINATION; COMPLEMENT HEMOLYSIS TEST; COOMBS TEST; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME ACTIVITY; ERYTHROCYTE TRANSFUSION; FEMALE; GESTATIONAL AGE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; LOW DRUG DOSE; MALE; MICROCIRCULATION; NEWBORN; PLASMA TRANSFUSION; PLASMAPHERESIS; POSTNATAL DEVELOPMENT; PREECLAMPSIA; PREGNANCY; PREGNANCY TERMINATION; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEINURIA; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; ULTRASOUND; BLOOD; BLOOD COMPONENT THERAPY; COLOR ULTRASOUND FLOWMETRY; FETUS ECHOGRAPHY; IMMUNOLOGY; LIVE BIRTH; METABOLISM; METHODOLOGY; PATIENT CARE; PREGNANCY COMPLICATION;

ADAM PROTEINS; AUTOANTIBODIES; BLOOD COMPONENT TRANSFUSION; CESAREAN SECTION; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LIVE BIRTH; MALE; PATIENT CARE TEAM; PLASMAPHERESIS; PLATELET COUNT; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PURPURA, THROMBOTIC THROMBOCYTOPENIC; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASONOGRAPHY, PRENATAL; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 62449242692     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-12-0739     Document Type: Article

References (24)

1. Parnas M, Sheiner E, Shoham-Vardi I, et al. Moderate to severe thrombocytopenia during pregnancy. Euro J Obstet Gynecol 2006; 128: 163-168.
2. Ajzenberg N, Dreyfus M, Kaplan C, et al. Pregnancy-associated thrombocytopenia revisited: assessment and follow-up of 50 cases. Blood 1998; 92: 4573-4580.
3. F.german RS, Witlin AG, Friedman SA, et al. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy: review of 11 cases. Am J Obstet Gynecol 1996; 175: 950-956.
4. Vesely SK, Li X, McMinn JR, et al. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2004; 44: 1149-1158.
5. Yamanaka Y, Takeuchi K, Oomori S, et al. Two cases of clinically suspected thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the puer-perium. Acta Obstet Gynecol Scand 2005; 84: 920-921.
6. McCrae KR, Cines DB. Thrombotic microangiopathy during pregnancy. Sernin Hematol 1997; 34: 148-158.
7. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-1584.
8. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-1594.
9. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488-494.
10. Donadelli R, Banterla F, Galbusera M, et al. Invito and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic thrombocytopenic purpura. Thromb Haemost 2006; 96: 454-464.
11. George KG. The role of ADAMTS 13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clin Adv Hematol Oncol 2005; 3: 627-632
12. Schneppenheim R, Budde U, Oyen F. et al. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood "FTP. Blood 2003; 101: 1845-1850.
13. Kentouche K, Zintl F, Angerhaus D, et al. von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem-cell transplantation. Sem Thromb Hemost 2006; 32: 98-104.
14. Franchini M. Haemostasis and pregnancy. Thromb Haemost 2006; 95: 401-413.
15. George N. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 2003; 10: 339-344
16. Mannucci PM, Canciani MT, Forza I, et al. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001; 98: 2730-2735.
17. Baeyer v H. Plasmapheresis in thrombotic microangiopathy-associated syndromes: Review of outcome data derived from clinical trials and open Studies. Ther Apher 2002; 6: 320-328.
18. Weiner CP. Thrombotic microangiopathy in pregnancy and the postpartum period. Semin Hematol 1987; 24: 119-129.
19. Proia A, Paesano R, Torcia F. et al. Thrombotic thrombocytopenic purpura and pregnancy: a case report and a review of the literature. Ann Hematol 2002; 81: 210-214.
20. Castellá M, Pujol M, Juliá A, et al. Thrombotic thrombocytopenic purpura and pregnancy: a review of ten cases. Vox Sang 2004; 87: 287-290.
21. Buyon JP. The effects of pregnancy on autoimmune diseases. J Leukoc Biol 1998; 63: 281-287.
22. Illter E, Haliloglu B, Temelli F, et al. Thrombotic thrombocytopenic purpura and pregnancy treated with fresh-frozen plasma infusions after plasmapheresis: a case report. Blood Coagul Fibrinolysis 2007; 18: 689-690.
23. Gunther K. Successful pregnancy despite thrombotic thrombocytopenic purpura in the first trimester. Transfusion 2006; 46: 1456-1457.
24. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic purpura. Canadian apheresis study group. N Engl J Med 1991; 325: 393-397.